<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35269723</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>08</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>Feb</Month><Day>25</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Biomarkers in Human Peripheral Blood Mononuclear Cells: The State of the Art in Amyotrophic Lateral Sclerosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2580</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms23052580</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease, characterized by the progressive loss of lower motor neurons, weakness and muscle atrophy. ALS lacks an effective cure and diagnosis is often made by exclusion. Thus, it is imperative to search for biomarkers. Biomarkers can help in understanding ALS pathomechanisms, identification of targets for treatment and development of effective therapies. Peripheral blood mononuclear cells (PBMCs) represent a valid source for biomarkers compared to cerebrospinal fluid, as they are simple to collect, and to plasma, because of the possibility of detecting lower expressed proteins. They are a reliable model for patients' stratification. This review provides an overview on PBMCs as a potential source of biomarkers in ALS. We focused on altered RNA metabolism (coding/non-coding RNA), including RNA processing, mRNA stabilization, transport and translation regulation. We addressed protein abnormalities (aggregation, misfolding and modifications); specifically, we highlighted that SOD1 appears to be the most characterizing protein in ALS. Finally, we emphasized the correlation between biological parameters and disease phenotypes, as regards prognosis, severity and clinical features. In conclusion, even though further studies are needed to standardize the use of PBMCs as a tool for biomarker investigation, they represent a promising approach in ALS research.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pansarasa</LastName><ForeName>Orietta</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0002-3041-0612</Identifier><AffiliationInfo><Affiliation>IRCCS Mondino Foundation, 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garofalo</LastName><ForeName>Maria</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-8668-3855</Identifier><AffiliationInfo><Affiliation>IRCCS Mondino Foundation, 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scarian</LastName><ForeName>Eveljn</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-6703-1755</Identifier><AffiliationInfo><Affiliation>IRCCS Mondino Foundation, 27100 Pavia, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Brain and Behavioral Sciences, University of Pavia, Via Forlanini 6, 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dragoni</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-7608-3306</Identifier><AffiliationInfo><Affiliation>IRCCS Mondino Foundation, 27100 Pavia, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garau</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>IRCCS Mondino Foundation, 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Gerlando</LastName><ForeName>Rosalinda</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>IRCCS Mondino Foundation, 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diamanti</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>IRCCS Mondino Foundation, 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bordoni</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>IRCCS Mondino Foundation, 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gagliardi</LastName><ForeName>Stella</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-6589-6907</Identifier><AffiliationInfo><Affiliation>IRCCS Mondino Foundation, 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>GR-2016-02361552</GrantID><Agency>Ministero della Salute</Agency><Country/></Grant><Grant><GrantID>RC2020-2021</GrantID><Agency>Ministero della Salute</Agency><Country/></Grant><Grant><GrantID>MLOpathy</GrantID><Agency>Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007963" MajorTopicYN="N">Leukocytes, Mononuclear</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">RNA metabolism</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">biomarkers</Keyword><Keyword MajorTopicYN="N">peripheral blood mononuclear cells</Keyword><Keyword MajorTopicYN="N">protein alterations</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>10</Day><Hour>15</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35269723</ArticleId><ArticleId IdType="pmc">PMC8910056</ArticleId><ArticleId IdType="doi">10.3390/ijms23052580</ArticleId><ArticleId IdType="pii">ijms23052580</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Erkkinen M.G., Kim M.-O., Geschwind M.D. Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases. Cold Spring Harb. Perspect. Biol. 2018;10:a033118. doi: 10.1101/cshperspect.a033118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a033118</ArticleId><ArticleId IdType="pmc">PMC5880171</ArticleId><ArticleId IdType="pubmed">28716886</ArticleId></ArticleIdList></Reference><Reference><Citation>Soto C., Pritzkow S. Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases. Nat. Neurosci. 2018;21:1332&#x2013;1340. doi: 10.1038/s41593-018-0235-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0235-9</ArticleId><ArticleId IdType="pmc">PMC6432913</ArticleId><ArticleId IdType="pubmed">30250260</ArticleId></ArticleIdList></Reference><Reference><Citation>Masrori P., Van Damme P. Amyotrophic lateral sclerosis: A clinical review. Eur. J. Neurol. 2020;27:1918&#x2013;1929. doi: 10.1111/ene.14393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14393</ArticleId><ArticleId IdType="pmc">PMC7540334</ArticleId><ArticleId IdType="pubmed">32526057</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O., Al-Chalabi A., Chio A., Corr E.M., Logroscino G., Robberecht W., Shaw P.J., Simmons Z., van den Berg L.H. Amyotrophic lateral sclerosis. Nat. Rev. Dis. Prim. 2017;3:17071. doi: 10.1038/nrdp.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown C.A., Lally C., Kupelian V., Flanders W.D. Estimated Prevalence and Incidence of Amyotrophic Lateral Sclerosis and SOD1 and C9orf72 Genetic Variants. Neuroepidemiology. 2021;55:342&#x2013;353. doi: 10.1159/000516752.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000516752</ArticleId><ArticleId IdType="pubmed">34247168</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusina R., Vandenberghe R., Bruffaerts R. Cognitive and Behavioral Manifestations in ALS: Beyond Motor System Involvement. Diagnostics. 2021;11:624. doi: 10.3390/diagnostics11040624.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics11040624</ArticleId><ArticleId IdType="pmc">PMC8065866</ArticleId><ArticleId IdType="pubmed">33808458</ArticleId></ArticleIdList></Reference><Reference><Citation>Bensimon G., Lacomblez L., Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N. Engl. J. Med. 1994;330:585&#x2013;591. doi: 10.1056/NEJM199403033300901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199403033300901</ArticleId><ArticleId IdType="pubmed">8302340</ArticleId></ArticleIdList></Reference><Reference><Citation>Alsultan A.A., Waller R., Heath P.R., Kirby J. The genetics of amyotrophic lateral sclerosis: Current insights. Degener. Neurol. Neuromuscul. Dis. 2016;6:49&#x2013;64. doi: 10.2147/DNND.S84956.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DNND.S84956</ArticleId><ArticleId IdType="pmc">PMC6053097</ArticleId><ArticleId IdType="pubmed">30050368</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejzini R., Flynn L.L., Pitout I.L., Fletcher S., Wilton S.D., Akkari P.A. ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now? Front. Neurosci. 2019;13:1310. doi: 10.3389/fnins.2019.01310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01310</ArticleId><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan M., Heverin M., McLaughlin R.L., Hardiman O. Lifetime Risk and Heritability of Amyotrophic Lateral Sclerosis. JAMA Neurol. 2019;76:1367&#x2013;1374. doi: 10.1001/jamaneurol.2019.2044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2019.2044</ArticleId><ArticleId IdType="pmc">PMC6646974</ArticleId><ArticleId IdType="pubmed">31329211</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingre C., Roos P.M., Piehl F., Kamel F., Fang F. Risk factors for amyotrophic lateral sclerosis. Clin. Epidemiol. 2015;7:181&#x2013;193. doi: 10.2147/CLEP.S37505.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CLEP.S37505</ArticleId><ArticleId IdType="pmc">PMC4334292</ArticleId><ArticleId IdType="pubmed">25709501</ArticleId></ArticleIdList></Reference><Reference><Citation>Heiman-Patterson T.D., Blankenhorn E.P., Sher R.B., Jiang J., Welsh P., Dixon M.C., Jeffrey J.I., Wong P., Cox G.A., Alexander G.M. Genetic background effects on disease onset and lifespan of the mutant dynactin p150Glued mouse model of motor neuron disease. PLoS ONE. 2015;10:e0117848. doi: 10.1371/journal.pone.0117848.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0117848</ArticleId><ArticleId IdType="pmc">PMC4357475</ArticleId><ArticleId IdType="pubmed">25763819</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O&#x2019;Regan J.P., Deng H.X. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Cereda C., Leoni E., Milani P., Pansarasa O., Mazzini G., Guareschi S., Alvisi E., Ghiroldi A., Diamanti L., Bernuzzi S., et al. Altered Intracellular Localization of SOD1 in Leukocytes from Patients with Sporadic Amyotrophic Lateral Sclerosis. PLoS ONE. 2013;8:e75916. doi: 10.1371/journal.pone.0075916.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0075916</ArticleId><ArticleId IdType="pmc">PMC3796534</ArticleId><ArticleId IdType="pubmed">24155874</ArticleId></ArticleIdList></Reference><Reference><Citation>Bordoni M., Pansarasa O., Dell&#x2019;Orco M., Crippa V., Gagliardi S., Sproviero D., Bernuzzi S., Diamanti L., Ceroni M., Tedeschi G., et al. Nuclear Phospho-SOD1 Protects DNA from Oxidative Stress Damage in Amyotrophic Lateral Sclerosis. J. Clin. Med. 2019;8:729. doi: 10.3390/jcm8050729.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm8050729</ArticleId><ArticleId IdType="pmc">PMC6572067</ArticleId><ArticleId IdType="pubmed">31121901</ArticleId></ArticleIdList></Reference><Reference><Citation>Obrador E., Salvador-Palmer R., L&#xf3;pez-Blanch R., Jihad-Jebbar A., Vall&#xe9;s S.L., Estrela J.M. The Link between Oxidative Stress, Redox Status, Bioenergetics and Mitochondria in the Pathophysiology of ALS. Int. J. Mol. Sci. 2021;22:6352. doi: 10.3390/ijms22126352.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22126352</ArticleId><ArticleId IdType="pmc">PMC8231819</ArticleId><ArticleId IdType="pubmed">34198557</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad A., Bharathi V., Sivalingam V., Girdhar A., Patel B.K. Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis. Front. Mol. Neurosci. 2019;12:25. doi: 10.3389/fnmol.2019.00025.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00025</ArticleId><ArticleId IdType="pmc">PMC6382748</ArticleId><ArticleId IdType="pubmed">30837838</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., Mann D., Tsuchiya K., Yoshida M., Hashizume Y., et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 2006;351:602&#x2013;611. doi: 10.1016/j.bbrc.2006.10.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwenk B.M., Hartmann H., Serdaroglu A., Schludi M.H., Hornburg D., Meissner F., Orozco D., Colombo A., Tahirovic S., Michaelsen M., et al. TDP-43 loss of function inhibits endosomal trafficking and alters trophic signaling in neurons. EMBO J. 2016;35:2350&#x2013;2370. doi: 10.15252/embj.201694221.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201694221</ArticleId><ArticleId IdType="pmc">PMC5090220</ArticleId><ArticleId IdType="pubmed">27621269</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu G., Coyne A.N., Pei F., Vaughan S., Chaung M., Zarnescu D.C., Buchan J.R. Endocytosis regulates TDP-43 toxicity and turnover. Nat. Commun. 2017;8:2092. doi: 10.1038/s41467-017-02017-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02017-x</ArticleId><ArticleId IdType="pmc">PMC5727062</ArticleId><ArticleId IdType="pubmed">29233983</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Li L., Lin W.-L., Dickson D.W., Petrucelli L., Zhang T., Wang X. The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons. Hum. Mol. Genet. 2013;22:4706&#x2013;4719. doi: 10.1093/hmg/ddt319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt319</ArticleId><ArticleId IdType="pmc">PMC3820133</ArticleId><ArticleId IdType="pubmed">23827948</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun R.J., Sommer C., Carmona-Gutierrez D., Khoury C.M., Ring J., B&#xfc;ttner S., Madeo F. Neurotoxic 43-kDa TAR DNA-binding protein (TDP-43) triggers mitochondrion-dependent programmed cell death in yeast. J. Biol. Chem. 2011;286:19958&#x2013;19972. doi: 10.1074/jbc.M110.194852.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.194852</ArticleId><ArticleId IdType="pmc">PMC3103370</ArticleId><ArticleId IdType="pubmed">21471218</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Zhou T., Wang T., Wang B. Suppression of lncRNA-ATB prevents amyloid-&#x3b2;-induced neurotoxicity in PC12 cells via regulating miR-200/ZNF217 axis. Biomed. Pharmacother. 2018;108:707&#x2013;715. doi: 10.1016/j.biopha.2018.08.155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2018.08.155</ArticleId><ArticleId IdType="pubmed">30248538</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan W., Li X., Shi J., Guo Y., Li Z., Li C. Mutant TAR DNA-binding protein-43 induces oxidative injury in motor neuron-like cell. Neuroscience. 2010;169:1621&#x2013;1629. doi: 10.1016/j.neuroscience.2010.06.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2010.06.018</ArticleId><ArticleId IdType="pubmed">20600671</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoica R., De Vos K.J., Paillusson S., Mueller S., Sancho R.M., Lau K.-F., Vizcay-Barrena G., Lin W.-L., Xu Y.-F., Lewis J., et al. ER-mitochondria associations are regulated by the VAPB-PTPIP51 interaction and are disrupted by ALS/FTD-associated TDP-43. Nat. Commun. 2014;5:3996. doi: 10.1038/ncomms4996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms4996</ArticleId><ArticleId IdType="pmc">PMC4046113</ArticleId><ArticleId IdType="pubmed">24893131</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X., Qiu H. Valosin-Containing Protein, a Calcium-Associated ATPase Protein, in Endoplasmic Reticulum and Mitochondrial Function and Its Implications for Diseases. Int. J. Mol. Sci. 2020;21:3842. doi: 10.3390/ijms21113842.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21113842</ArticleId><ArticleId IdType="pmc">PMC7312078</ArticleId><ArticleId IdType="pubmed">32481679</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H.-X., Zhai H., Bigio E.H., Yan J., Fecto F., Ajroud K., Mishra M., Ajroud-Driss S., Heller S., Sufit R., et al. FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis. Ann. Neurol. 2010;67:739&#x2013;748. doi: 10.1002/ana.22051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22051</ArticleId><ArticleId IdType="pmc">PMC4376270</ArticleId><ArticleId IdType="pubmed">20517935</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolan M., Talbot K., Ansorge O. Pathogenesis of FUS-associated ALS and FTD: Insights from rodent models. Acta Neuropathol. Commun. 2016;4:99. doi: 10.1186/s40478-016-0358-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0358-8</ArticleId><ArticleId IdType="pmc">PMC5011941</ArticleId><ArticleId IdType="pubmed">27600654</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Majounie E., Waite A., Sim&#xf3;n-S&#xe1;nchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., van Swieten J.C., Myllykangas L., et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R., Isaacs A.M. C9orf72-mediated ALS and FTD: Multiple pathways to disease. Nat. Rev. Neurol. 2018;14:544&#x2013;558. doi: 10.1038/s41582-018-0047-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0047-2</ArticleId><ArticleId IdType="pmc">PMC6417666</ArticleId><ArticleId IdType="pubmed">30120348</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogh I., Ratti A., Gellera C., Lin K., Tiloca C., Moskvina V., Corrado L., Sorar&#xf9; G., Cereda C., Corti S., et al. A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis. Hum. Mol. Genet. 2014;23:2220&#x2013;2231. doi: 10.1093/hmg/ddt587.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt587</ArticleId><ArticleId IdType="pmc">PMC3959809</ArticleId><ArticleId IdType="pubmed">24256812</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie T., Deng L., Mei P., Zhou Y., Wang B., Zhang J., Lin J., Wei Y., Zhang X., Xu R. Genome-wide association study combining pathway analysis for typical sporadic amyotrophic lateral sclerosis in Chinese Han populations. Neurobiol. Aging. 2014;35:1778.e9&#x2013;1778.e23. doi: 10.1016/j.neurobiolaging.2014.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.01.014</ArticleId><ArticleId IdType="pubmed">24529757</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M., Xi Z., Saez-Atienzar S., Chia R., Moreno D., Sato C., Montazer Haghighi M., Traynor B.J., Zinman L., Rogaeva E. Combined epigenetic/genetic study identified an ALS age of onset modifier. Acta Neuropathol. Commun. 2021;9:75. doi: 10.1186/s40478-021-01183-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-021-01183-w</ArticleId><ArticleId IdType="pmc">PMC8066440</ArticleId><ArticleId IdType="pubmed">33892821</ArticleId></ArticleIdList></Reference><Reference><Citation>Califf R.M. Biomarker definitions and their applications. Exp. Biol. Med. 2018;243:213&#x2013;221. doi: 10.1177/1535370217750088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1535370217750088</ArticleId><ArticleId IdType="pmc">PMC5813875</ArticleId><ArticleId IdType="pubmed">29405771</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosado M., Silva R., G Bexiga M., G Jones J., Manadas B., Anjo S.I. Advances in biomarker detection: Alternative approaches for blood-based biomarker detection. Adv. Clin. Chem. 2019;92:141&#x2013;199. doi: 10.1016/bs.acc.2019.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.acc.2019.04.003</ArticleId><ArticleId IdType="pubmed">31472753</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosallaei M., Ehtesham N., Rahimirad S., Saghi M., Vatandoost N., Khosravi S. PBMCs: A new source of diagnostic and prognostic biomarkers. Arch. Physiol. Biochem. 2020 doi: 10.1080/13813455.2020.1752257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13813455.2020.1752257</ArticleId><ArticleId IdType="pubmed">32293207</ArticleId></ArticleIdList></Reference><Reference><Citation>Zondler L., M&#xfc;ller K., Khalaji S., Bliederh&#xe4;user C., Ruf W.P., Grozdanov V., Thiemann M., Fundel-Clemes K., Freischmidt A., Holzmann K., et al. Peripheral monocytes are functionally altered and invade the CNS in ALS patients. Acta Neuropathol. 2016;132:391&#x2013;411. doi: 10.1007/s00401-016-1548-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1548-y</ArticleId><ArticleId IdType="pubmed">26910103</ArticleId></ArticleIdList></Reference><Reference><Citation>Verber N.S., Shepheard S.R., Sassani M., McDonough H.E., Moore S.A., Alix J.J.P., Wilkinson I.D., Jenkins T.M., Shaw P.J. Biomarkers in Motor Neuron Disease: A State of the Art Review. Front. Neurol. 2019;10:291. doi: 10.3389/fneur.2019.00291.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00291</ArticleId><ArticleId IdType="pmc">PMC6456669</ArticleId><ArticleId IdType="pubmed">31001186</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H., Garcon G., Patin F., Veyrat-Durebex C., Boyer J., Devos D., Vourc&#x2019;h P., Andres C.R., Corcia P. Panel of Oxidative Stress and Inflammatory Biomarkers in ALS: A Pilot Study. Can. J. Neurol. Sci. Le J. Can. des Sci. Neurol. 2017;44:90&#x2013;95. doi: 10.1017/cjn.2016.284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/cjn.2016.284</ArticleId><ArticleId IdType="pubmed">27774920</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardo G., Pozzi S., Pignataro M., Lauranzano E., Spano G., Garbelli S., Mantovani S., Marinou K., Papetti L., Monteforte M., et al. Amyotrophic lateral sclerosis multiprotein biomarkers in peripheral blood mononuclear cells. PLoS ONE. 2011;6:e25545. doi: 10.1371/journal.pone.0025545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0025545</ArticleId><ArticleId IdType="pmc">PMC3187793</ArticleId><ArticleId IdType="pubmed">21998667</ArticleId></ArticleIdList></Reference><Reference><Citation>Luotti S., Pasetto L., Porcu L., Torri V., Elezgarai S.R., Pantalone S., Filareti M., Corbo M., Lunetta C., Mora G., et al. Diagnostic and prognostic values of PBMC proteins in amyotrophic lateral sclerosis. Neurobiol. Dis. 2020;139:104815. doi: 10.1016/j.nbd.2020.104815.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.104815</ArticleId><ArticleId IdType="pubmed">32087285</ArticleId></ArticleIdList></Reference><Reference><Citation>Leoni E., Bremang M., Mitra V., Zubiri I., Jung S., Lu C.-H., Adiutori R., Lombardi V., Russell C., Koncarevic S., et al. Combined Tissue-Fluid Proteomics to Unravel Phenotypic Variability in Amyotrophic Lateral Sclerosis. Sci. Rep. 2019;9:4478. doi: 10.1038/s41598-019-40632-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-40632-4</ArticleId><ArticleId IdType="pmc">PMC6418138</ArticleId><ArticleId IdType="pubmed">30872628</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X., Feng W., Huang R., Guo X., Chen Y., Zheng Z., Shang H. Evidence for peripheral immune activation in amyotrophic lateral sclerosis. J. Neurol. Sci. 2014;347:90&#x2013;95. doi: 10.1016/j.jns.2014.09.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2014.09.025</ArticleId><ArticleId IdType="pubmed">25312013</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdock B.J., Zhou T., Kashlan S.R., Little R.J., Goutman S.A., Feldman E.L. Correlation of Peripheral Immunity With Rapid Amyotrophic Lateral Sclerosis Progression. JAMA Neurol. 2017;74:1446&#x2013;1454. doi: 10.1001/jamaneurol.2017.2255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.2255</ArticleId><ArticleId IdType="pmc">PMC5822195</ArticleId><ArticleId IdType="pubmed">28973548</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustafson M.P., Staff N.P., Bornschlegl S., Butler G.W., Maas M.L., Kazamel M., Zubair A., Gastineau D.A., Windebank A.J., Dietz A.B. Comprehensive immune profiling reveals substantial immune system alterations in a subset of patients with amyotrophic lateral sclerosis. PLoS ONE. 2017;12:e0182002. doi: 10.1371/journal.pone.0182002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0182002</ArticleId><ArticleId IdType="pmc">PMC5526569</ArticleId><ArticleId IdType="pubmed">28742871</ArticleId></ArticleIdList></Reference><Reference><Citation>McGill R.B., Steyn F.J., Ngo S.T., Thorpe K.A., Heggie S., Ruitenberg M.J., Henderson R.D., McCombe P.A., Woodruff T.M. Monocytes and neutrophils are associated with clinical features in amyotrophic lateral sclerosis. Brain Commun. 2020;2:fcaa013. doi: 10.1093/braincomms/fcaa013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa013</ArticleId><ArticleId IdType="pmc">PMC7530830</ArticleId><ArticleId IdType="pubmed">33033799</ArticleId></ArticleIdList></Reference><Reference><Citation>Rolfes L., Schulte-Mecklenbeck A., Schreiber S., Vielhaber S., Herty M., Marten A., Pfeuffer S., Ruck T., Wiendl H., Gross C.C., et al. Amyotrophic lateral sclerosis patients show increased peripheral and intrathecal T-cell activation. Brain Commun. 2021;3:fcab157. doi: 10.1093/braincomms/fcab157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcab157</ArticleId><ArticleId IdType="pmc">PMC8363480</ArticleId><ArticleId IdType="pubmed">34405141</ArticleId></ArticleIdList></Reference><Reference><Citation>Giovannelli I., Heath P., Shaw P.J., Kirby J. The involvement of regulatory T cells in amyotrophic lateral sclerosis and their therapeutic potential. Amyotroph. Lateral Scler. Frontotemporal Degener. 2020;21:435&#x2013;444. doi: 10.1080/21678421.2020.1752246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1752246</ArticleId><ArticleId IdType="pubmed">32484719</ArticleId></ArticleIdList></Reference><Reference><Citation>Coque E., Salsac C., Espinosa-Carrasco G., Varga B., Degauque N., Cadoux M., Crab&#xe9; R., Virenque A., Soulard C., Fierle J.K., et al. Cytotoxic CD8(+) T lymphocytes expressing ALS-causing SOD1 mutant selectively trigger death of spinal motoneurons. Proc. Natl. Acad. Sci. USA. 2019;116:2312&#x2013;2317. doi: 10.1073/pnas.1815961116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1815961116</ArticleId><ArticleId IdType="pmc">PMC6369778</ArticleId><ArticleId IdType="pubmed">30674678</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantas D., Kostakis I.D., Machairas N., Markopoulos C. White blood cell and platelet indices as prognostic markers in patients with invasive ductal breast carcinoma. Oncol. Lett. 2016;12:1610&#x2013;1614. doi: 10.3892/ol.2016.4760.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ol.2016.4760</ArticleId><ArticleId IdType="pmc">PMC4950562</ArticleId><ArticleId IdType="pubmed">27446480</ArticleId></ArticleIdList></Reference><Reference><Citation>Mati&#x107; I.Z., Kolund&#x17e;ija B., Damjanovi&#x107; A., Spasi&#x107; J., Radosavljevi&#x107; D., &#x110;or&#x111;i&#x107; Crnogorac M., Grozdani&#x107; N., Jurani&#x107; Z.D. Peripheral White Blood Cell Subsets in Metastatic Colorectal Cancer Patients Treated with Cetuximab: The Potential Clinical Relevance. Front. Immunol. 2017;8:1886. doi: 10.3389/fimmu.2017.01886.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01886</ArticleId><ArticleId IdType="pmc">PMC5758541</ArticleId><ArticleId IdType="pubmed">29354119</ArticleId></ArticleIdList></Reference><Reference><Citation>Silvestre-Roig C., Fridlender Z.G., Glogauer M., Scapini P. Neutrophil Diversity in Health and Disease. Trends Immunol. 2019;40:565&#x2013;583. doi: 10.1016/j.it.2019.04.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2019.04.012</ArticleId><ArticleId IdType="pmc">PMC7185435</ArticleId><ArticleId IdType="pubmed">31160207</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagliardi S., Milani P., Sardone V., Pansarasa O., Cereda C. From Transcriptome to Noncoding RNAs: Implications in ALS Mechanism. Neurol. Res. Int. 2012;2012:278725. doi: 10.1155/2012/278725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/278725</ArticleId><ArticleId IdType="pmc">PMC3385659</ArticleId><ArticleId IdType="pubmed">22778949</ArticleId></ArticleIdList></Reference><Reference><Citation>Butti Z., Patten S.A. RNA dysregulation in amyotrophic lateral sclerosis. Front. Genet. 2019;10:712. doi: 10.3389/fgene.2018.00712.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2018.00712</ArticleId><ArticleId IdType="pmc">PMC6349704</ArticleId><ArticleId IdType="pubmed">30723494</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski T.J.J., Bosco D.A., Leclerc A.L., Tamrazian E., Vanderburg C.R., Russ C., Davis A., Gilchrist J., Kasarskis E.J., Munsat T., et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323:1205&#x2013;1208. doi: 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutherford N.J., Zhang Y.-J., Baker M., Gass J.M., Finch N.A., Xu Y.-F., Stewart H., Kelley B.J., Kuntz K., Crook R.J.P., et al. Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. PLoS Genet. 2008;4:e1000193. doi: 10.1371/journal.pgen.1000193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1000193</ArticleId><ArticleId IdType="pmc">PMC2527686</ArticleId><ArticleId IdType="pubmed">18802454</ArticleId></ArticleIdList></Reference><Reference><Citation>Mougeot J.L.C., Li Z., Price A.E., Wright F.A., Brooks B.R. Microarray analysis of peripheral blood lymphocytes from ALS patients and the SAFE detection of the KEGG ALS pathway. BMC Med. Genom. 2011;4:74. doi: 10.1186/1755-8794-4-74.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1755-8794-4-74</ArticleId><ArticleId IdType="pmc">PMC3219589</ArticleId><ArticleId IdType="pubmed">22027401</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymenidou M., Lagier-Tourenne C., Hutt K.R., Huelga S.C., Moran J., Liang T.Y., Ling S.C., Sun E., Wancewicz E., Mazur C., et al. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat. Neurosci. 2011;14:459&#x2013;468. doi: 10.1038/nn.2779.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2779</ArticleId><ArticleId IdType="pmc">PMC3094729</ArticleId><ArticleId IdType="pubmed">21358643</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapeli K., Pratt G.A., Vu A.Q., Hutt K.R., Martinez F.J., Sundararaman B., Batra R., Freese P., Lambert N.J., Huelga S.C., et al. Distinct and shared functions of ALS-associated proteins TDP-43, FUS and TAF15 revealed by multisystem analyses. Nat. Commun. 2016;7:12143. doi: 10.1038/ncomms12143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms12143</ArticleId><ArticleId IdType="pmc">PMC4935974</ArticleId><ArticleId IdType="pubmed">27378374</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamelgarn M., Chen J., Kuang L., Jin H., Kasarskis E.J., Zhu H. ALS mutations of FUS suppress protein translation and disrupt the regulation of nonsense-mediated decay. Proc. Natl. Acad. Sci. USA. 2018;115:E11904&#x2013;E11913. doi: 10.1073/pnas.1810413115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1810413115</ArticleId><ArticleId IdType="pmc">PMC6304956</ArticleId><ArticleId IdType="pubmed">30455313</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C., Wang Z., Zhang J., Zhao X., Xu P., Liu X., Li M., Lv C., Song X. Crosstalk of mRNA, miRNA, lncRNA, and circRNA and Their Regulatory Pattern in Pulmonary Fibrosis. Mol. Ther. Nucleic Acids. 2019;18:204&#x2013;218. doi: 10.1016/j.omtn.2019.08.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtn.2019.08.018</ArticleId><ArticleId IdType="pmc">PMC6796619</ArticleId><ArticleId IdType="pubmed">31561125</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Wang Z. Efficient backsplicing produces translatable circular mRNAs. RNA. 2015;21:172&#x2013;179. doi: 10.1261/rna.048272.114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.048272.114</ArticleId><ArticleId IdType="pmc">PMC4338345</ArticleId><ArticleId IdType="pubmed">25449546</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopp F., Mendell J.T. Functional Classification and Experimental Dissection of Long Noncoding RNAs. Cell. 2018;172:393&#x2013;407. doi: 10.1016/j.cell.2018.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.01.011</ArticleId><ArticleId IdType="pmc">PMC5978744</ArticleId><ArticleId IdType="pubmed">29373828</ArticleId></ArticleIdList></Reference><Reference><Citation>Memczak S., Jens M., Elefsinioti A., Torti F., Krueger J., Rybak A., Maier L., Mackowiak S.D., Gregersen L.H., Munschauer M., et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495:333&#x2013;338. doi: 10.1038/nature11928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11928</ArticleId><ArticleId IdType="pubmed">23446348</ArticleId></ArticleIdList></Reference><Reference><Citation>Errichelli L., Dini Modigliani S., Laneve P., Colantoni A., Legnini I., Capauto D., Rosa A., De Santis R., Scarf&#xf2; R., Peruzzi G., et al. FUS affects circular RNA expression in murine embryonic stem cell-derived motor neurons. Nat. Commun. 2017;8:14741. doi: 10.1038/ncomms14741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms14741</ArticleId><ArticleId IdType="pmc">PMC5379105</ArticleId><ArticleId IdType="pubmed">28358055</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagliardi S., Pandini C., Garofalo M., Bordoni M., Pansarasa O., Cereda C. Long non coding RNAs and ALS: Still much to do. Non-Coding RNA Res. 2018;3:226&#x2013;231. doi: 10.1016/j.ncrna.2018.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncrna.2018.11.004</ArticleId><ArticleId IdType="pmc">PMC6260474</ArticleId><ArticleId IdType="pubmed">30533570</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Arai S., Song X., Reichart D., Du K., Pascual G., Tempst P., Rosenfeld M.G., Glass C.K., Kurokawa R. Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature. 2008;454:126&#x2013;130. doi: 10.1038/nature06992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature06992</ArticleId><ArticleId IdType="pmc">PMC2823488</ArticleId><ArticleId IdType="pubmed">18509338</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang S., Zhang L., Guo J., Niu Y., Wu Y., Li H., Zhao L., Li X., Teng X., Sun X., et al. NONCODEV5: A comprehensive annotation database for long non-coding RNAs. Nucleic Acids Res. 2018;46:D308&#x2013;D314. doi: 10.1093/nar/gkx1107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx1107</ArticleId><ArticleId IdType="pmc">PMC5753287</ArticleId><ArticleId IdType="pubmed">29140524</ArticleId></ArticleIdList></Reference><Reference><Citation>Moens T.G., Mizielinska S., Niccoli T., Mitchell J.S., Thoeng A., Ridler C.E., Gr&#xf6;nke S., Esser J., Heslegrave A., Zetterberg H., et al. Sense and antisense RNA are not toxic in Drosophila models of C9orf72-associated ALS/FTD. Acta Neuropathol. 2018;135:445&#x2013;457. doi: 10.1007/s00401-017-1798-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1798-3</ArticleId><ArticleId IdType="pmc">PMC6385858</ArticleId><ArticleId IdType="pubmed">29380049</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagliardi S., Cova E., Davin A., Guareschi S., Abel K., Alvisi E., Laforenza U., Ghidoni R., Cashman J.R., Ceroni M., et al. SOD1 mRNA expression in sporadic amyotrophic lateral sclerosis. Neurobiol. Dis. 2010;39:198&#x2013;203. doi: 10.1016/j.nbd.2010.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2010.04.008</ArticleId><ArticleId IdType="pubmed">20399857</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu L., Zheng L., Viera L., Suswam E., Li Y., Li X., Est&#xe9;vez A.G., King P.H. Mutant Cu/Zn-superoxide dismutase associated with amyotrophic lateral sclerosis destabilizes vascular endothelial growth factor mRNA and downregulates its expression. J. Neurosci. 2007;27:7929&#x2013;7938. doi: 10.1523/JNEUROSCI.1877-07.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1877-07.2007</ArticleId><ArticleId IdType="pmc">PMC6672720</ArticleId><ArticleId IdType="pubmed">17652584</ArticleId></ArticleIdList></Reference><Reference><Citation>Gijselinck I., Van Langenhove T., van der Zee J., Sleegers K., Philtjens S., Kleinberger G., Janssens J., Bettens K., Van Cauwenberghe C., Pereson S., et al. A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: A gene identification study. Lancet Neurol. 2012;11:54&#x2013;65. doi: 10.1016/S1474-4422(11)70261-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(11)70261-7</ArticleId><ArticleId IdType="pubmed">22154785</ArticleId></ArticleIdList></Reference><Reference><Citation>Sellier C., Rau F., Liu Y., Tassone F., Hukema R.K., Gattoni R., Schneider A., Richard S., Willemsen R., Elliott D.J., et al. Sam68 sequestration and partial loss of function are associated with splicing alterations in FXTAS patients. EMBO J. 2010;29:1248&#x2013;1261. doi: 10.1038/emboj.2010.21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2010.21</ArticleId><ArticleId IdType="pmc">PMC2857464</ArticleId><ArticleId IdType="pubmed">20186122</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagliardi S., Zucca S., Pandini C., Diamanti L., Bordoni M., Sproviero D., Arigoni M., Olivero M., Pansarasa O., Ceroni M., et al. Long non-coding and coding RNAs characterization in Peripheral Blood Mononuclear Cells and Spinal Cord from Amyotrophic Lateral Sclerosis patients. Sci. Rep. 2018;8:2378. doi: 10.1038/s41598-018-20679-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-20679-5</ArticleId><ArticleId IdType="pmc">PMC5799454</ArticleId><ArticleId IdType="pubmed">29402919</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Erchia A.M., Gallo A., Manzari C., Raho S., Horner D.S., Chiara M., Valletti A., Aiello I., Mastropasqua F., Ciaccia L., et al. Massive transcriptome sequencing of human spinal cord tissues provides new insights into motor neuron degeneration in ALS. Sci. Rep. 2017;7:10046. doi: 10.1038/s41598-017-10488-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-10488-7</ArticleId><ArticleId IdType="pmc">PMC5577269</ArticleId><ArticleId IdType="pubmed">28855684</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguirre T., Van Den Bosch L., Goetschalckx K., Tilkin P., Mathijs G., Cassiman J.J., Robberecht W. Increased sensitivity of fibroblasts from amyotrophic lateral sclerosis patients to oxidative stress. Ann. Neurol. 1998;43:452&#x2013;457. doi: 10.1002/ana.410430407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410430407</ArticleId><ArticleId IdType="pubmed">9546325</ArticleId></ArticleIdList></Reference><Reference><Citation>Clement A.M., Nguyen M.D., Roberts E.A., Garcia M.L., Boill&#xe9;e S., Rule M., McMahon A.P., Doucette W., Siwek D., Ferrante R.J., et al. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science. 2003;302:113&#x2013;117. doi: 10.1126/science.1086071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1086071</ArticleId><ArticleId IdType="pubmed">14526083</ArticleId></ArticleIdList></Reference><Reference><Citation>Curti D., Malaspina A., Facchetti G., Camana C., Mazzini L., Tosca P., Zerbi F., Ceroni M. Amyotrophic lateral sclerosis: Oxidative energy metabolism and calcium homeostasis in peripheral blood lymphocytes. Neurology. 1996;47:1060&#x2013;1064. doi: 10.1212/WNL.47.4.1060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.47.4.1060</ArticleId><ArticleId IdType="pubmed">8857745</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono S. The skin in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 2000;1:191&#x2013;199. doi: 10.1080/14660820050515188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820050515188</ArticleId><ArticleId IdType="pubmed">11464952</ArticleId></ArticleIdList></Reference><Reference><Citation>Ku&#x17a;ma-Kozakiewicz M., Ka&#x17a;mierczak B., Chudy A., Gajewska B., Bara&#x144;czyk-Ku&#x17a;ma A. Alteration of Motor Protein Expression Involved in Bidirectional Transport in Peripheral Blood Mononuclear Cells of Patients with Amyotrophic Lateral Sclerosis. Neurodegener. Dis. 2016;16:235&#x2013;244. doi: 10.1159/000443664.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000443664</ArticleId><ArticleId IdType="pubmed">26954557</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta P.K., Prabhakar S., Abburi C., Sharma N.K., Anand A. Vascular endothelial growth factor-A and chemokine ligand (CCL2) genes are upregulated in peripheral blood mononuclear cells in Indian amyotrophic lateral sclerosis patients. J. Neuroinflamm. 2011;8:114. doi: 10.1186/1742-2094-8-114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-8-114</ArticleId><ArticleId IdType="pmc">PMC3177897</ArticleId><ArticleId IdType="pubmed">21906274</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondratskyi A., Kondratska K., Skryma R., Klionsky D.J., Prevarskaya N. Ion channels in the regulation of autophagy. Autophagy. 2018;14:3&#x2013;21. doi: 10.1080/15548627.2017.1384887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2017.1384887</ArticleId><ArticleId IdType="pmc">PMC5846505</ArticleId><ArticleId IdType="pubmed">28980859</ArticleId></ArticleIdList></Reference><Reference><Citation>Nachmany H., Wald S., Abekasis M., Bulvik S., Weil M. Two potential biomarkers identified in mesenchymal stem cells and leukocytes of patients with sporadic amyotrophic lateral sclerosis. Dis. Markers. 2012;32:211&#x2013;220. doi: 10.1155/2012/824692.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/824692</ArticleId><ArticleId IdType="pmc">PMC3826586</ArticleId><ArticleId IdType="pubmed">22430187</ArticleId></ArticleIdList></Reference><Reference><Citation>Vrabec K., Bo&#x161;tjan&#x10d;i&#x10d; E., Koritnik B., Leonardis L., Dolenc Gro&#x161;elj L., Zidar J., Rogelj B., Glava&#x10d; D., Ravnik-Glava&#x10d; M. Differential Expression of Several miRNAs and the Host Genes AATK and DNM2 in Leukocytes of Sporadic ALS Patients. Front. Mol. Neurosci. 2018;11:106. doi: 10.3389/fnmol.2018.00106.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00106</ArticleId><ArticleId IdType="pmc">PMC5893848</ArticleId><ArticleId IdType="pubmed">29670510</ArticleId></ArticleIdList></Reference><Reference><Citation>Liguori M., Nuzziello N., Introna A., Consiglio A., Licciulli F., D&#x2019;Errico E., Scarafino A., Distaso E., Simone I.L. Dysregulation of MicroRNAs and Target Genes Networks in Peripheral Blood of Patients With Sporadic Amyotrophic Lateral Sclerosis. Front. Mol. Neurosci. 2018;11:288. doi: 10.3389/fnmol.2018.00288.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00288</ArticleId><ArticleId IdType="pmc">PMC6121079</ArticleId><ArticleId IdType="pubmed">30210287</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Rheenen W., Diekstra F.P., Harschnitz O., Westeneng H.-J., van Eijk K.R., Saris C.G.J., Groen E.J.N., van Es M.A., Blauw H.M., van Vught P.W.J., et al. Whole blood transcriptome analysis in amyotrophic lateral sclerosis: A biomarker study. PLoS ONE. 2018;13:e0198874. doi: 10.1371/journal.pone.0198874.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0198874</ArticleId><ArticleId IdType="pmc">PMC6016933</ArticleId><ArticleId IdType="pubmed">29939990</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W., Beers D.R., Hooten K.G., Sieglaff D.H., Zhang A., Kalyana-Sundaram S., Traini C.M., Halsey W.S., Hughes A.M., Sathe G.M., et al. Characterization of Gene Expression Phenotype in Amyotrophic Lateral Sclerosis Monocytes. JAMA Neurol. 2017;74:677&#x2013;685. doi: 10.1001/jamaneurol.2017.0357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.0357</ArticleId><ArticleId IdType="pmc">PMC5822209</ArticleId><ArticleId IdType="pubmed">28437540</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravnik-Glava&#x10d; M., Glava&#x10d; D. Circulating RNAs as Potential Biomarkers in Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci. 2020;21:1714. doi: 10.3390/ijms21051714.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21051714</ArticleId><ArticleId IdType="pmc">PMC7084402</ArticleId><ArticleId IdType="pubmed">32138249</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayakumar U.G., Milla V., Cynthia Stafford M.Y., Bjourson A.J., Duddy W., Duguez S.M.-R. A Systematic Review of Suggested Molecular Strata, Biomarkers and Their Tissue Sources in ALS. Front. Neurol. 2019;10:400. doi: 10.3389/fneur.2019.00400.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00400</ArticleId><ArticleId IdType="pmc">PMC6527847</ArticleId><ArticleId IdType="pubmed">31139131</ArticleId></ArticleIdList></Reference><Reference><Citation>De Felice B., Manfellotto F., Fiorentino G., Annunziata A., Biffali E., Pannone R., Federico A. Wide-Ranging Analysis of MicroRNA Profiles in Sporadic Amyotrophic Lateral Sclerosis Using Next-Generation Sequencing. Front. Genet. 2018;9:310. doi: 10.3389/fgene.2018.00310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2018.00310</ArticleId><ArticleId IdType="pmc">PMC6102490</ArticleId><ArticleId IdType="pubmed">30154826</ArticleId></ArticleIdList></Reference><Reference><Citation>De Felice B., Guida M., Guida M., Coppola C., De Mieri G., Cotrufo R. A miRNA signature in leukocytes from sporadic amyotrophic lateral sclerosis. Gene. 2012;508:35&#x2013;40. doi: 10.1016/j.gene.2012.07.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2012.07.058</ArticleId><ArticleId IdType="pubmed">22903028</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Wei Q., Chen X., Li C., Cao B., Ou R., Hadano S., Shang H.-F. Aberration of miRNAs Expression in Leukocytes from Sporadic Amyotrophic Lateral Sclerosis. Front. Mol. Neurosci. 2016;9:69. doi: 10.3389/fnmol.2016.00069.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2016.00069</ArticleId><ArticleId IdType="pmc">PMC4987348</ArticleId><ArticleId IdType="pubmed">27582688</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv J., Zeng Y., Qian Y., Dong J., Zhang Z., Zhang J. MicroRNA let-7c-5p improves neurological outcomes in a murine model of traumatic brain injury by suppressing neuroinflammation and regulating microglial activation. Brain Res. 2018;1685:91&#x2013;104. doi: 10.1016/j.brainres.2018.01.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2018.01.032</ArticleId><ArticleId IdType="pubmed">29408500</ArticleId></ArticleIdList></Reference><Reference><Citation>Parisi C., Napoli G., Amadio S., Spalloni A., Apolloni S., Longone P., Volont&#xe9; C. MicroRNA-125b regulates microglia activation and motor neuron death in ALS. Cell Death Differ. 2016;23:531&#x2013;541. doi: 10.1038/cdd.2015.153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2015.153</ArticleId><ArticleId IdType="pmc">PMC5072447</ArticleId><ArticleId IdType="pubmed">26794445</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X., Zhang H. miR-451 elevation relieves inflammatory pain by suppressing microglial activation-evoked inflammatory response via targeting TLR4. Cell Tissue Res. 2018;374:487&#x2013;495. doi: 10.1007/s00441-018-2898-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-018-2898-7</ArticleId><ArticleId IdType="pubmed">30069596</ArticleId></ArticleIdList></Reference><Reference><Citation>Kos A., de Mooij-Malsen A.J., van Bokhoven H., Kaplan B.B., Martens G.J., Kolk S.M., Aschrafi A. MicroRNA-338 modulates cortical neuronal placement and polarity. RNA Biol. 2017;14:905&#x2013;913. doi: 10.1080/15476286.2017.1325067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15476286.2017.1325067</ArticleId><ArticleId IdType="pmc">PMC5546544</ArticleId><ArticleId IdType="pubmed">28494198</ArticleId></ArticleIdList></Reference><Reference><Citation>Zolboot N., Du J.X., Zampa F., Lippi G. MicroRNAs Instruct and Maintain Cell Type Diversity in the Nervous System. Front. Mol. Neurosci. 2021;14:69. doi: 10.3389/fnmol.2021.646072.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2021.646072</ArticleId><ArticleId IdType="pmc">PMC8116551</ArticleId><ArticleId IdType="pubmed">33994943</ArticleId></ArticleIdList></Reference><Reference><Citation>Maragakis N.J., Dykes-Hoberg M., Rothstein J.D. Altered expression of the glutamate transporter EAAT2b in neurological disease. Ann. Neurol. 2004;55:469&#x2013;477. doi: 10.1002/ana.20003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20003</ArticleId><ArticleId IdType="pubmed">15048885</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams A.H., Valdez G., Moresi V., Qi X., McAnally J., Elliott J.L., Bassel-Duby R., Sanes J.R., Olson E.N. MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science. 2009;326:1549&#x2013;1554. doi: 10.1126/science.1181046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1181046</ArticleId><ArticleId IdType="pmc">PMC2796560</ArticleId><ArticleId IdType="pubmed">20007902</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Pietro L., Baranzini M., Berardinelli M.G., Lattanzi W., Monforte M., Tasca G., Conte A., Logroscino G., Michetti F., Ricci E., et al. Potential therapeutic targets for ALS: MIR206, MIR208b and MIR499 are modulated during disease progression in the skeletal muscle of patients. Sci. Rep. 2017;7:9538. doi: 10.1038/s41598-017-10161-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-10161-z</ArticleId><ArticleId IdType="pmc">PMC5573384</ArticleId><ArticleId IdType="pubmed">28842714</ArticleId></ArticleIdList></Reference><Reference><Citation>Doose G., Haake A., Bernhart S.H., L&#xf3;pez C., Duggimpudi S., Wojciech F., Bergmann A.K., Borkhardt A., Burkhardt B., Claviez A., et al. MINCR is a MYC-induced lncRNA able to modulate MYC&#x2019;s transcriptional network in Burkitt lymphoma cells. Proc. Natl. Acad. Sci. USA. 2015;112:E5261&#x2013;E5270. doi: 10.1073/pnas.1505753112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1505753112</ArticleId><ArticleId IdType="pmc">PMC4586867</ArticleId><ArticleId IdType="pubmed">26351698</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S.-H., Yang Y., Wu X.-C., Zhang M.-D., Weng M.-Z., Zhou D., Wang J.-D., Quan Z.-W. Long non-coding RNA MINCR promotes gallbladder cancer progression through stimulating EZH2 expression. Cancer Lett. 2016;380:122&#x2013;133. doi: 10.1016/j.canlet.2016.06.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.canlet.2016.06.019</ArticleId><ArticleId IdType="pubmed">27345740</ArticleId></ArticleIdList></Reference><Reference><Citation>Lian J., Zhang X., Lu Y., Hao S., Zhang Z., Yang Y. Expression and Significance of LncRNA-MINCR and CDK2 mRNA in Primary Hepatocellular Carcinoma. Comb. Chem. High Throughput Screen. 2019;22:201&#x2013;206. doi: 10.2174/1386207322666190404151020.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1386207322666190404151020</ArticleId><ArticleId IdType="pubmed">30947664</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Gu T., Lu Z., Qiu L., Xiao G., Zhu X., Li F., Yu H., Li G., Liu H. Roles of MYC-targeting long non-coding RNA MINCR in cell cycle regulation and apoptosis in non-small cell lung Cancer. Respir. Res. 2019;20:202. doi: 10.1186/s12931-019-1174-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-019-1174-z</ArticleId><ArticleId IdType="pmc">PMC6724276</ArticleId><ArticleId IdType="pubmed">31481083</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyu Q., Jin L., Yang X., Zhang F. LncRNA MINCR activates Wnt/&#x3b2;-catenin signals to promote cell proliferation and migration in oral squamous cell carcinoma. Pathol. Res. Pract. 2019;215:924&#x2013;930. doi: 10.1016/j.prp.2019.01.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.prp.2019.01.041</ArticleId><ArticleId IdType="pubmed">30777615</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong Q., Chen Y., Chen Z. LncRNA MINCR regulates irradiation resistance in nasopharyngeal carcinoma cells via the microRNA-223/ZEB1 axis. Cell Cycle. 2020;19:53&#x2013;66. doi: 10.1080/15384101.2019.1692176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15384101.2019.1692176</ArticleId><ArticleId IdType="pmc">PMC6927709</ArticleId><ArticleId IdType="pubmed">31760895</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z., Xie X., Fan X., Li X. Long Non-coding RNA MINCR Regulates miR-876-5p/GSPT1 Axis to Aggravate Glioma Progression. Neurochem. Res. 2020;45:1690&#x2013;1699. doi: 10.1007/s11064-020-03029-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-020-03029-8</ArticleId><ArticleId IdType="pubmed">32333234</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandini C., Garofalo M., Rey F., Garau J., Zucca S., Sproviero D., Bordoni M., Berzero G., Davin A., Poloni T.E., et al. MINCR: A long non-coding RNA shared between cancer and neurodegeneration. Genomics. 2021;113:4039&#x2013;4051. doi: 10.1016/j.ygeno.2021.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ygeno.2021.10.008</ArticleId><ArticleId IdType="pubmed">34662711</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolinar A., Koritnik B., Glava&#x10d; D., Ravnik-Glava&#x10d; M. Circular RNAs as Potential Blood Biomarkers in Amyotrophic Lateral Sclerosis. Mol. Neurobiol. 2019;56:8052&#x2013;8062. doi: 10.1007/s12035-019-1627-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-019-1627-x</ArticleId><ArticleId IdType="pmc">PMC6834740</ArticleId><ArticleId IdType="pubmed">31175544</ArticleId></ArticleIdList></Reference><Reference><Citation>Benson B.C., Shaw P.J., Azzouz M., Highley J.R., Hautbergue G.M. Proteinopathies as Hallmarks of Impaired Gene Expression, Proteostasis and Mitochondrial Function in Amyotrophic Lateral Sclerosis. Front. Neurosci. 2021;15:783624. doi: 10.3389/fnins.2021.783624.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2021.783624</ArticleId><ArticleId IdType="pmc">PMC8733206</ArticleId><ArticleId IdType="pubmed">35002606</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi E.S., Dokholyan N. V SOD1 oligomers in amyotrophic lateral sclerosis. Curr. Opin. Struct. Biol. 2021;66:225&#x2013;230. doi: 10.1016/j.sbi.2020.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sbi.2020.12.002</ArticleId><ArticleId IdType="pmc">PMC7965251</ArticleId><ArticleId IdType="pubmed">33465527</ArticleId></ArticleIdList></Reference><Reference><Citation>Park H.R., Yang E.J. Oxidative Stress as a Therapeutic Target in Amyotrophic Lateral Sclerosis: Opportunities and Limitations. Diagnostics. 2021;11:1546. doi: 10.3390/diagnostics11091546.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics11091546</ArticleId><ArticleId IdType="pmc">PMC8465946</ArticleId><ArticleId IdType="pubmed">34573888</ArticleId></ArticleIdList></Reference><Reference><Citation>Cova E., Cereda C., Galli A., Curti D., Finotti C., Di Poto C., Corato M., Mazzini G., Ceroni M. Modified expression of Bcl-2 and SOD1 proteins in lymphocytes from sporadic ALS patients. Neurosci. Lett. 2006;399:186&#x2013;190. doi: 10.1016/j.neulet.2006.01.057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2006.01.057</ArticleId><ArticleId IdType="pubmed">16495003</ArticleId></ArticleIdList></Reference><Reference><Citation>Garofalo M., Pandini C., Bordoni M., Jacchetti E., Diamanti L., Carelli S., Raimondi M.T., Sproviero D., Crippa V., Carra S., et al. RNA Molecular Signature Profiling in PBMCs of Sporadic ALS Patients: HSP70 Overexpression Is Associated with Nuclear SOD1. Cells. 2022;11:293. doi: 10.3390/cells11020293.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11020293</ArticleId><ArticleId IdType="pmc">PMC8774074</ArticleId><ArticleId IdType="pubmed">35053410</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R., Rademakers R., Neumann M. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol. 2010;9:995&#x2013;1007. doi: 10.1016/S1474-4422(10)70195-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70195-2</ArticleId><ArticleId IdType="pubmed">20864052</ArticleId></ArticleIdList></Reference><Reference><Citation>De Marco G., Lupino E., Calvo A., Moglia C., Buccinn&#xe0; B., Grifoni S., Ramondetti C., Lomartire A., Rinaudo M.T., Piccinini M., et al. Cytoplasmic accumulation of TDP-43 in circulating lymphomonocytes of ALS patients with and without TARDBP mutations. Acta Neuropathol. 2011;121:611&#x2013;622. doi: 10.1007/s00401-010-0786-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-010-0786-7</ArticleId><ArticleId IdType="pubmed">21120508</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X., Chen J., Liu W., Li X., Chen Q., Liu T., Gao S., Deng M. The fused in sarcoma protein forms cytoplasmic aggregates in motor neurons derived from integration-free induced pluripotent stem cells generated from a patient with familial amyotrophic lateral sclerosis carrying the FUS-P525L mutation. Neurogenetics. 2015;16:223&#x2013;231. doi: 10.1007/s10048-015-0448-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10048-015-0448-y</ArticleId><ArticleId IdType="pubmed">25912081</ArticleId></ArticleIdList></Reference><Reference><Citation>Pansarasa O., Bordoni M., Drufuca L., Diamanti L., Sproviero D., Trotti R., Bernuzzi S., La Salvia S., Gagliardi S., Ceroni M., et al. Lymphoblastoid cell lines as a model to understand amyotrophic lateral sclerosis disease mechanisms. Dis. Model. Mech. 2018;11:dmm031625. doi: 10.1242/dmm.031625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.031625</ArticleId><ArticleId IdType="pmc">PMC5897724</ArticleId><ArticleId IdType="pubmed">29419416</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleary J.D., Ranum L.P.W. Repeat-associated non-ATG (RAN) translation in neurological disease. Hum. Mol. Genet. 2013;22:R45&#x2013;R51. doi: 10.1093/hmg/ddt371.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt371</ArticleId><ArticleId IdType="pmc">PMC3782068</ArticleId><ArticleId IdType="pubmed">23918658</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkins H.M., Dimachkie M.M., Agbas A. In: Blood-Based Biomarkers for Amyotrophic Lateral Sclerosis. Araki T., editor. Exon Publications; Brisbane, Australia: 2021.</Citation></Reference><Reference><Citation>Nonaka T., Masuda-Suzukake M., Hosokawa M., Shimozawa A., Hirai S., Okado H., Hasegawa M. C9ORF72 dipeptide repeat poly-GA inclusions promote intracellular aggregation of phosphorylated TDP-43. Hum. Mol. Genet. 2018;27:2658&#x2013;2670. doi: 10.1093/hmg/ddy174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddy174</ArticleId><ArticleId IdType="pubmed">29750243</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrade N.S., Ramic M., Esanov R., Liu W., Rybin M.J., Gaidosh G., Abdallah A., Del&#x2019;Olio S., Huff T.C., Chee N.T., et al. Dipeptide repeat proteins inhibit homology-directed DNA double strand break repair in C9ORF72 ALS/FTD. Mol. Neurodegener. 2020;15:13. doi: 10.1186/s13024-020-00365-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-020-00365-9</ArticleId><ArticleId IdType="pmc">PMC7041170</ArticleId><ArticleId IdType="pubmed">32093728</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron T.F., Chew J., Stankowski J.N., Hayes L.R., Zhang Y.-J., Prudencio M., Carlomagno Y., Daughrity L.M., Jansen-West K., Perkerson E.A., et al. Poly(GP) proteins are a useful pharmacodynamic marker for C9ORF72-associated amyotrophic lateral sclerosis. Sci. Transl. Med. 2017;9:eaai7866. doi: 10.1126/scitranslmed.aai7866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aai7866</ArticleId><ArticleId IdType="pmc">PMC5576451</ArticleId><ArticleId IdType="pubmed">28356511</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Kodavati M., Britz G.W., Hegde M.L. DNA Damage and Repair Deficiency in ALS/FTD-Associated Neurodegeneration: From Molecular Mechanisms to Therapeutic Implication. Front. Mol. Neurosci. 2021;14:784361. doi: 10.3389/fnmol.2021.784361.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2021.784361</ArticleId><ArticleId IdType="pmc">PMC8716463</ArticleId><ArticleId IdType="pubmed">34975400</ArticleId></ArticleIdList></Reference><Reference><Citation>Vats A., Gourie-Devi M., Ahuja K., Sharma A., Wajid S., Ganguly N.K., Taneja V. Expression analysis of protein homeostasis pathways in the peripheral blood mononuclear cells of sporadic amyotrophic lateral sclerosis patients. J. Neurol. Sci. 2018;387:85&#x2013;91. doi: 10.1016/j.jns.2018.01.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2018.01.035</ArticleId><ArticleId IdType="pubmed">29571878</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J., Lehmensiek V., Mogel H., Pfeifle M., Dorst J., Hendrich C., Ludolph A.C., Tumani H. Proteome analysis reveals candidate markers of disease progression in amyotrophic lateral sclerosis (ALS) Neurosci. Lett. 2010;468:23&#x2013;27. doi: 10.1016/j.neulet.2009.10.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2009.10.053</ArticleId><ArticleId IdType="pubmed">19853641</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryberg H., An J., Darko S., Lustgarten J.L., Jaffa M., Gopalakrishnan V., Lacomis D., Cudkowicz M., Bowser R. Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics. Muscle Nerve. 2010;42:104&#x2013;111. doi: 10.1002/mus.21683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.21683</ArticleId><ArticleId IdType="pmc">PMC2975276</ArticleId><ArticleId IdType="pubmed">20583124</ArticleId></ArticleIdList></Reference><Reference><Citation>Conraux L., Pech C., Guerraoui H., Loyaux D., Ferrara P., Guillemot J.-C., Meininger V., Pradat P.-F., Salachas F., Bruneteau G., et al. Plasma peptide biomarker discovery for amyotrophic lateral sclerosis by MALDI-TOF mass spectrometry profiling. PLoS ONE. 2013;8:e79733. doi: 10.1371/journal.pone.0079733.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0079733</ArticleId><ArticleId IdType="pmc">PMC3818176</ArticleId><ArticleId IdType="pubmed">24224000</ArticleId></ArticleIdList></Reference><Reference><Citation>Wormser U., Mandrioli J., Vinceti M., Fini N., Sintov A., Brodsky B., Proskura E., Finkelstein Y. Reduced levels of alpha-1-antitrypsin in cerebrospinal fluid of amyotrophic lateral sclerosis patients: A novel approach for a potential treatment. J. Neuroinflamm. 2016;13:131. doi: 10.1186/s12974-016-0589-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0589-4</ArticleId><ArticleId IdType="pmc">PMC4888657</ArticleId><ArticleId IdType="pubmed">27245439</ArticleId></ArticleIdList></Reference><Reference><Citation>Kon&#x10d;arevi&#x107; S., L&#xf6;&#xdf;ner C., Kuhn K., Prinz T., Pike I., Zucht H.-D. In-depth profiling of the peripheral blood mononuclear cells proteome for clinical blood proteomics. Int. J. Proteom. 2014;2014:129259. doi: 10.1155/2014/129259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/129259</ArticleId><ArticleId IdType="pmc">PMC3958665</ArticleId><ArticleId IdType="pubmed">24724028</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardo G., Pozzi S., Mantovani S., Garbelli S., Marinou K., Basso M., Mora G., Bendotti C., Bonetto V. Nitroproteomics of peripheral blood mononuclear cells from patients and a rat model of ALS. Antioxid. Redox Signal. 2009;11:1559&#x2013;1567. doi: 10.1089/ars.2009.2548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2009.2548</ArticleId><ArticleId IdType="pubmed">19290778</ArticleId></ArticleIdList></Reference><Reference><Citation>Filareti M., Luotti S., Pasetto L., Pignataro M., Paolella K., Messina P., Pupillo E., Filosto M., Lunetta C., Mandrioli J., et al. Decreased Levels of Foldase and Chaperone Proteins Are Associated with an Early-Onset Amyotrophic Lateral Sclerosis. Front. Mol. Neurosci. 2017;10:99. doi: 10.3389/fnmol.2017.00099.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00099</ArticleId><ArticleId IdType="pmc">PMC5382314</ArticleId><ArticleId IdType="pubmed">28428745</ArticleId></ArticleIdList></Reference><Reference><Citation>Malaspina A., Puentes F., Amor S. Disease origin and progression in amyotrophic lateral sclerosis: An immunology perspective. Int. Immunol. 2015;27:117&#x2013;129. doi: 10.1093/intimm/dxu099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxu099</ArticleId><ArticleId IdType="pubmed">25344935</ArticleId></ArticleIdList></Reference><Reference><Citation>Stankiewicz T.R., Linseman D.A. Rho family GTPases: Key players in neuronal development, neuronal survival, and neurodegeneration. Front. Cell. Neurosci. 2014;8:314. doi: 10.3389/fncel.2014.00314.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00314</ArticleId><ArticleId IdType="pmc">PMC4187614</ArticleId><ArticleId IdType="pubmed">25339865</ArticleId></ArticleIdList></Reference><Reference><Citation>Roser A.-E., T&#xf6;nges L., Lingor P. Modulation of Microglial Activity by Rho-Kinase (ROCK) Inhibition as Therapeutic Strategy in Parkinson&#x2019;s Disease and Amyotrophic Lateral Sclerosis. Front. Aging Neurosci. 2017;9:94. doi: 10.3389/fnagi.2017.00094.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00094</ArticleId><ArticleId IdType="pmc">PMC5378706</ArticleId><ArticleId IdType="pubmed">28420986</ArticleId></ArticleIdList></Reference><Reference><Citation>Giraudon P., Vincent P., Vuaillat C. T-cells in neuronal injury and repair: Semaphorins and related T-cell signals. Neuromol. Med. 2005;7:207&#x2013;216. doi: 10.1385/NMM:7:3:207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1385/NMM:7:3:207</ArticleId><ArticleId IdType="pubmed">16247181</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W., Beers D.R., Thonhoff J.R., Thome A.D., Faridar A., Wang J., Wen S., Ornelas L., Sareen D., Goodridge H.S., et al. Immunosuppressive Functions of M2 Macrophages Derived from iPSCs of Patients with ALS and Healthy Controls. iScience. 2020;23:101192. doi: 10.1016/j.isci.2020.101192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2020.101192</ArticleId><ArticleId IdType="pmc">PMC7286967</ArticleId><ArticleId IdType="pubmed">32521508</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Y., Zhao W., Thonhoff J.R., Wang J., Wen S., Appel S.H. Increased activation ability of monocytes from ALS patients. Exp. Neurol. 2020;328:113259. doi: 10.1016/j.expneurol.2020.113259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2020.113259</ArticleId><ArticleId IdType="pubmed">32105709</ArticleId></ArticleIdList></Reference><Reference><Citation>Swindell W.R., Kruse C.P.S., List E.O., Berryman D.E., Kopchick J.J. ALS blood expression profiling identifies new biomarkers, patient subgroups, and evidence for neutrophilia and hypoxia. J. Transl. Med. 2019;17:170. doi: 10.1186/s12967-019-1909-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-019-1909-0</ArticleId><ArticleId IdType="pmc">PMC6530130</ArticleId><ArticleId IdType="pubmed">31118040</ArticleId></ArticleIdList></Reference><Reference><Citation>Arosio B., D&#x2019;Addario C., Gussago C., Casati M., Tedone E., Ferri E., Nicolini P., Rossi P.D., Maccarrone M., Mari D. Peripheral blood mononuclear cells as a laboratory to study dementia in the elderly. Biomed Res. Int. 2014;2014:169203. doi: 10.1155/2014/169203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/169203</ArticleId><ArticleId IdType="pmc">PMC4022117</ArticleId><ArticleId IdType="pubmed">24877062</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>